About
Abuse Deterrents
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
528
By Phase
PHASE2: 3PHASE3: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
Today
Hover over trial bars to see details
Recent Trials
NCT01759446Lead Sponsor
Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users
PHASE2Completed
44 participants
Started: Feb 28, 2013 · Completed: Apr 30, 2013
NCT01030406Lead Sponsor
Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
PHASE2Completed
49 participants
Started: Jan 31, 2010 · Completed: Feb 28, 2010
NCT00699010Lead Sponsor
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
PHASE2Completed
30 participants
Started: Mar 31, 2008 · Completed: Aug 31, 2008
NCT00654069Lead Sponsor
Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy
PHASE3Completed
405 participants
Started: Sep 30, 2007 · Completed: Mar 31, 2008
Locations (1)
Headquarters
Palatine, IL, United States
Map
Loading map...